Evidence map›Paper›PMID 39015553›Full record

ArticleDementia & neuropsychologia2024

Neuropsychological aspects of reversible cerebral vasoconstriction syndrome.

Ícaro Araújo de Sousa, Analina de Freitas Azevedo, Arthur de Oliveira Veras, Marx Lima de Barros-Araújo, Elizeu Pereira Dos Santos, Maria Andreia da Nóbrega Marques, Maria Paula Foss, Raimundo Pereira Silva-Néto, Irapuá Ferreira Ricarte, Octávio Marques Pontes-Neto

Abstract read
In one paragraph

Article in Dementia & neuropsychologia, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Ícaro Araújo de SousaUniversidade de São Paulo, Faculdade de Medicina de Ribeirão Preto, Departamento de Neurociências e Ciências do Comportamento, Ribeirão Preto SP, Brazil.ORCID https://orcid.org/0000-0002-9452-1207
Analina de Freitas AzevedoUniversidade Federal do Piauí, Hospital Universitário, Departamento de Medicina Especializada, Teresina PI, Brazil.ORCID https://orcid.org/0009-0002-2068-2961
Arthur de Oliveira VerasUniversidade de São Paulo, Faculdade de Medicina de Ribeirão Preto, Departamento de Neurociências e Ciências do Comportamento, Ribeirão Preto SP, Brazil.ORCID https://orcid.org/0000-0001-8865-177X
Marx Lima de Barros-AraújoUniversidade Federal do Piauí, Hospital Universitário, Departamento de Medicina Especializada, Teresina PI, Brazil.ORCID https://orcid.org/0000-0002-9943-1294
Elizeu Pereira Dos SantosUniversidade de São Paulo, Hospital das Clínicas, Instituto de Radiologia, São Paulo SP, Brazil.ORCID https://orcid.org/0000-0002-8791-4440
Maria Andreia da Nóbrega MarquesUniversidade do Estado do Piauí, Departamento de Psicologia, Teresina PI, Brazil.ORCID https://orcid.org/0000-0003-1607-6301
Maria Paula FossUniversidade de São Paulo, Faculdade de Filosofia, Ciências e Letras de Ribeirão Preto, Departamento de Psicologia, Ribeirão Preto SP, Brazil.ORCID https://orcid.org/0000-0003-1420-2423
Raimundo Pereira Silva-NétoUniversidade Federal do Delta do Parnaíba, Departamento de Neurologia, Paraíba PI, Brazil.ORCID https://orcid.org/0000-0002-2343-9679
Irapuá Ferreira RicarteUniversidade Federal de São Paulo Escola Paulista de Medicina, Departamento de Neurologia e Neurocirurgia, São Paulo SP, Brazil.ORCID https://orcid.org/0000-0002-6866-153X
Octávio Marques Pontes-NetoUniversidade de São Paulo, Faculdade de Medicina de Ribeirão Preto, Departamento de Neurociências e Ciências do Comportamento, Ribeirão Preto SP, Brazil.ORCID https://orcid.org/0000-0003-0317-843X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite the increasing knowledge in the past years, only minimal attention has been directed to the neuropsychological aspects and the prevalence of cognitive impairment associated with reversible cerebral vasoconstriction syndrome (RCVS). Objective: To describe the frequency and expand the understanding of cognitive dysfunction in RCVS. Methods: The neuropsychological evaluation was performed using a battery consisting of specific neuropsychological instruments that were administered to patients diagnosed with RCVS. A triage was conducted to exclude other potential causes of cognitive impairment. Performance on the tests was treated as a categorical variable, and a cutoff of -1.5 Z-score was adopted to indicate impaired performance. Results: Seven patients diagnosed with RCVS were evaluated, all of whom had a bachelor's degree and normal score in the Mini-Mental State Examination. The average time between diagnosis and neuropsychological evaluation was 1.8 years. Among the patients, 85.6% (n=6) exhibited performance below that of the normal population in at least two of the administered tests. Specifically, 71.4% (n=5) showed alterations in tests from the Psychological Battery for Attention Assessment, with impairment observed in concentrated (n=1), divided (n=3), or alternating (n=4) attention. Furthermore, 28.6% (n=2) demonstrated impairments in the Phonological Verbal Fluency Task, another 28.6% (n=2) exhibited difficulties copying elements of the Rey Complex Figure, and 14.3% (n=1) displayed lower performance in the Five-Digit test, all indicating executive dysfunction. Conclusion: This study provides evidence that cognitive impairment associated with RCVS is more prevalent than previously believed and has not received sufficient attention. Specifically, attention and executive functions are the cognitive domains most significantly impacted by RCVS.

Indexed as

Cognitive DysfunctionIschemic StrokeNeuropsychologyVasoconstriction

Identifiers

PMID39015553
PMCPMC11251691

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.